NEW UK Autism Research Hub: The Synapse Centre for Neurodevelopment ESNEFT
NEW UK Autism Research Hub: The Synapse Centre for Neurodevelopment ESNEFT The Synapse Centre for Neurodevelopment The Synapse Centre, based within the ESNEFT (East Suffolk and North Essex NHS Foundation Trust) is a new research centre based in the East of England...
Synchrony 2020 Online Symposium – Translational Research In Autism
Synchrony 2020 Online Symposium – Translational Research In Autism Latest advancements in autism research and development of approved therapeutics for improving health and quality of life of people with autism. We are happy to share the announcement that the second...
Synchrony 2019 – Translational Research in Autism symposia
The first Brain Foundation annual symposia, Pleasanton, California 8-10 of Nov 2019, aimed to connect researchers with clinicians, donors & stake holders to help translate research efforts into evidence-based treatments for autism and its co-morbidities. It highlighted the need for multidisciplinary collaboration, detailed diagnostics and personalised treatment…
Higher rates of autism in children with various congenital disorders
Children with Congenital Heart Disease, Tuberous Sclerosis Complex, Duchenne Muscular Dystrophy, Ehlers-Danlos Syndrome, Neurofibromatosis Type 1 suffer high rates of autism. Everolimus, an mTOR inhibitor with strong neuro-inflammation attenuating effects, reduces core autism symptoms in some children with TSC, epilepsy and autism…
Perinatal risk factors and pregnancy complication associated with autism
Babies who are exposed to perinatal complicatios incl. asphyxia, preeclampsia, and meconium-stained amniotic fluid, are at increased risk of developing autism. The risk is especially high for babies exposed to complications both before and during birth.